Qiagen N.V. Stock News

GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)---- $QGEN--QIAGEN plans to resubmit EUA submission in the U.S. for QIAreach SARS-CoV-2 Antigen Test in the first quarter of 2021

GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)---- $QGEN--QIAGEN confirms effectiveness of its SARS-CoV-2 PCR tests in the face of mutations of the coronavirus

The resurgence in coronavirus infections is drawing attention back to the diagnostic testing space.

VENLO, The Netherlands--(BUSINESS WIRE)---- $QGEN--QIAGEN announces appointment of new Supervisory Board member

Despite MedTech industry's bright prospects in 2021, investors should be wary of stocks like BLFS, STAA and TGTX, given their unfavorable Zacks Rank and weak fundamentals.

VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN--QIAGEN underlines and innovates its commitment to sustainability with a EUR 400mn sustainability-linked credit facility

VENLO, The Netherlands--(BUSINESS WIRE)---- $QGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) ("QIAGEN" or the "Company") announces the successful pricing of the following series of trans

VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN--QIAGEN increases outlook for 2020 and 2021

HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)---- $QGEN--QIAGEN to launch QuantiFERON SARS-CoV-2 for research into causes, spread and control of COVID-19 through T-cell response

Much healthcare investment attention is dominated by COVID-19, but other needs persist, including diagnostics provision and research. One investor asks about QIAGEN's current prospects and competitors

Qiagen has been a beneficiary of COVID related tailwinds particularly as related to COVID testing, which has driven strong revenue growth and profitability. Several new products set to come to market

Qiagen NV QGEN shares rose in the extended session Wednesday after the Netherlands-based medical diagnostics company said it will begin selling a portable COVID-19 test in the United States. Qiagen sh

VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced it would hold a conference call on Wednesday, October 28, after releasing full results

VENLO, the Netherlands--(BUSINESS WIRE)---- $QGEN--QIAGEN reports strong results for third quarter and first nine months of 2020 and increases outlook for full-year 2020